Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

NovaBev reported for 2023 by IFRS

3/14/24 BELU

Moscow Exchange is working to identify unfair practices at auctions

3/14/24 MOEX

Basis plans to take 50% of the virtualization systems market in Russia

3/14/24 RTKM

Element Group will go public by the end of 2024

3/14/24 AFKS

Krasnoyarskenergosbyt reported for 2023 by RAS

3/14/24 KRSB

Died Vice-President of Lukoil Vitaly Robertus

3/14/24 LKOH

Severstal started construction of a complex in Cherepovets

3/13/24 CHMF

Drones damaged installations of Ryazan NPK

3/13/24 ROSN

JSFC Sistema will develop hydrogen technologies in the SEZ of Mordovia

3/13/24 AFKS

Yandex.Market began testing Roboruka

3/13/24 YNDX